Free delivery over $100 Learn more

30 days return period Learn more
SKU: 0683ATC

KYSE410 Human Esophageal Squamous Cell Carcinoma Epithelial Cells

Tumor Cell Lines > Esophageal Cancer Cell Lines

Product Type: Human Esophageal Cancer Cell Lines

Species: Human

Cell Type: Epithelial Cells

Source Organ: Other

$1,249.00
Size

Care information

Display general product information or specific product information using metafields.

Delivery and Shipping

Add some general information about your delivery and shipping policies.

Cell Name: KYSE410

Established from the poorly differentiated invasive oesophageal squamous cell carcinoma resected from the cervical oesophagus of a 51-year old Japanese man prior to treatment.

  • Description
    KYSE410 is a human esophageal squamous cell carcinoma (ESCC) cell line derived from a poorly differentiated, invasive tumor resected from a 51-year-old Japanese male patient. This epithelial-like cell line exhibits adherent growth in monolayers with a doubling time of approximately 45 hours. KYSE410 harbors mutations in TP53 and KRAS, and demonstrates overexpresses of oncogenic markers such as heparin-binding growth factor (hst-1) and cyclin D1. The cell line is tumorigenic in nude mice, readily forming subcutaneous tumors upon xenotransplantation. It retains key features of genomic instability, characteristic of advanced ESCC.
  • Product Name
    KYSE410
  • Product Type
    Human Esophageal Cancer Cell Lines
  • Species
    Human
  • Cell Type
    Epithelial-like
  • Disease
    Esophageal Squamous Cell Cancer
  • Product Type
    Human Esophageal Cancer Cell Lines
  • Growth Conditions
    37 °C, 5% CO2
  • Application
    The KYSE410 cell line serves as a valuable in vitro model for studying pathogenesis and molecular biology of human esophageal squamous cell carcinoma. Its tumorigenic properties and defined mutational landscape make it particularly suited for investigating oncogenic signaling pathways, especially those involving TP53 and KRAS mutations. Researchers commonly utilize KYSE410 in preclinical drug screening, evaluating the efficacy of chemotherapeutic agents and targeted therapies, including inhibitors of EGFR and cyclin D1 pathways. Additionally, the cell line supports studies on tumor progression, metastasis, and resistance mechanisms, contributing to the development of novel therapeutic strategies for ESCC.
  • Size/Quantity
    1 vial
  • Recommended Medium And Supplement

    RPMI 1640 + 10% FBS
  • Shipping Conditions
    Dry Ice
  • Storage
    Liquid Nitrogen
  • Biosafety Level
    1

Payment & Security

Payment methods

    Your payment information is processed securely. We do not store credit card details nor have access to your credit card information.

    • Visit our support center

      Expert help & advice

    • Check your order status

      Updates & tracking

    • Returns & exchanges

      All you need to know

    • Price-match guarantee

      Our promise to you